NO20010620L - Vitronektinreseptor-antagonister - Google Patents

Vitronektinreseptor-antagonister

Info

Publication number
NO20010620L
NO20010620L NO20010620A NO20010620A NO20010620L NO 20010620 L NO20010620 L NO 20010620L NO 20010620 A NO20010620 A NO 20010620A NO 20010620 A NO20010620 A NO 20010620A NO 20010620 L NO20010620 L NO 20010620L
Authority
NO
Norway
Prior art keywords
alkyl
het
halogen
6alkyl
co2r9
Prior art date
Application number
NO20010620A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010620D0 (no
Inventor
Peter J Manley
William H Miller
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20010620D0 publication Critical patent/NO20010620D0/no
Publication of NO20010620L publication Critical patent/NO20010620L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20010620A 1998-08-07 2001-02-06 Vitronektinreseptor-antagonister NO20010620L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9570398P 1998-08-07 1998-08-07
PCT/US1999/017665 WO2000007544A2 (fr) 1998-08-07 1999-08-03 Antagonistes du recepteur de la proteine s

Publications (2)

Publication Number Publication Date
NO20010620D0 NO20010620D0 (no) 2001-02-06
NO20010620L true NO20010620L (no) 2001-02-06

Family

ID=22253229

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010620A NO20010620L (no) 1998-08-07 2001-02-06 Vitronektinreseptor-antagonister

Country Status (18)

Country Link
US (1) US6458814B1 (fr)
EP (1) EP1102587A4 (fr)
JP (1) JP2002522360A (fr)
KR (1) KR20010086355A (fr)
CN (1) CN1322133A (fr)
AR (1) AR020121A1 (fr)
AU (1) AU5336299A (fr)
BR (1) BR9912638A (fr)
CA (1) CA2339666A1 (fr)
CO (1) CO5170532A1 (fr)
CZ (1) CZ2001447A3 (fr)
HU (1) HUP0103090A3 (fr)
IL (1) IL141163A0 (fr)
NO (1) NO20010620L (fr)
PL (1) PL346157A1 (fr)
TR (1) TR200100363T2 (fr)
WO (1) WO2000007544A2 (fr)
ZA (1) ZA200100935B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
DE60130910T2 (de) 2000-04-17 2008-07-10 Ucb Pharma, S.A. Enamin-derivate als zell-adhäsionsmoleküle
US7119098B2 (en) 2000-06-15 2006-10-10 Pharmacia Corporation Heteroarylakanoic acids as intergrin receptor antagonists
FR2847254B1 (fr) * 2002-11-19 2005-01-28 Aventis Pharma Sa Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant
JP2006516144A (ja) 2002-12-20 2006-06-22 ファルマシア・コーポレーション インテグリン受容体アンタゴニスト誘導体としてのチアゾール化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59108771A (ja) * 1982-12-13 1984-06-23 Taiho Yakuhin Kogyo Kk オキサゾール誘導体
FI922867A7 (fi) * 1991-06-21 1992-12-22 Tanabe Seiyaku Co Dikarbonsyraderivat och foerfarande foer framstaellning av dem
DK0623615T3 (da) * 1993-05-01 1999-12-13 Merck Patent Gmbh Adhæsionsreceptor-antagonister
US5756466A (en) * 1994-06-17 1998-05-26 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
NZ290008A (en) * 1994-06-29 1998-08-26 Smithkline Beecham Corp Vitronectin receptor antagonists, comprising a fibrinogen antagonist analogue linked to a heterocycle

Also Published As

Publication number Publication date
ZA200100935B (en) 2002-05-14
CN1322133A (zh) 2001-11-14
EP1102587A4 (fr) 2003-03-12
WO2000007544A3 (fr) 2000-05-18
BR9912638A (pt) 2001-05-02
US6458814B1 (en) 2002-10-01
WO2000007544A2 (fr) 2000-02-17
KR20010086355A (ko) 2001-09-10
NO20010620D0 (no) 2001-02-06
HUP0103090A3 (en) 2002-12-28
HUP0103090A2 (hu) 2002-01-28
CO5170532A1 (es) 2002-06-27
AU5336299A (en) 2000-02-28
EP1102587A2 (fr) 2001-05-30
JP2002522360A (ja) 2002-07-23
TR200100363T2 (tr) 2001-06-21
CA2339666A1 (fr) 2000-02-17
AR020121A1 (es) 2002-04-10
PL346157A1 (en) 2002-01-28
IL141163A0 (en) 2002-02-10
CZ2001447A3 (cs) 2001-08-15

Similar Documents

Publication Publication Date Title
US7820654B2 (en) Pyrimidine compounds, process for their preparation and compositions containing them
FI81090C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,4-dihydropyridiner och daervid anvaendbara mellanprodukter.
ES2536779T3 (es) Compuestos de N-fenil-(piperazinil u homopiperazinil)-bencensulfonamida o bencensulfonil-fenil-(piperazina u homopiperazina) adecuados para tratar trastornos que responden a la modulación del receptor de serotonina 5-HT6
ES2244469T3 (es) Fenilpiperazinas como inhibidores de la recaptacion de serotonina.
NO341631B1 (no) Hydroksybenzamidderivater og deres anvendelse, fremgangsmåte for fremstilling og farmasøytiske sammensetninger
DK2343281T3 (en) Process for the Synthesis of Phenoxydiamino-Pyrimidine Derivatives
NO20073667L (no) [4-(heteroaryl) piperazin-1-yl]-(2,5-substituert-fenyl)metanonderivater som glycintransportor 1(GLYT-1)- inhibitorer for behandling av neurologiske og neuropsykiatriske lidelser
MXPA05002839A (es) Derivados de 1-piridin-4-il-urea.
AR071314A1 (es) Antagonistas de receptor de cgrp
PT1533304E (pt) Derivado de amida
NO20062489L (no) Heterocykliske anti-migrenemidler
PE20070462A1 (es) Compuestos derivados de fenilaminopropanol
BRPI0710121A2 (pt) compostos, processos para a fabricação de compostos; composições farmacêuticas; método para o tratamento e/ou prevenção de doenças associadas à modulação de receptores de sst subtipo 5 e uso de compostos
AR035759A1 (es) Compuestos acilurea antagonistas de la funcion mpc-1, un procedimiento para su preparacion, composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos
RU2011125917A (ru) Производные фенилпиримидона, фармацевтические композиции, способы их получения и применения
NO20010620L (no) Vitronektinreseptor-antagonister
PE20091243A1 (es) Compuesto heterociclico fusionado
AR029400A1 (es) Derivados de isoxazolcarboxamida, un metodo para su preparacion y una composicion farmaceutica que los comprende
NO20062648L (no) Calcitonin gen relaterte peptid reseptor antagonister
HRP20080274T3 (en) 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
JP2008534472A5 (fr)
CA2931804A1 (fr) Derives piperidine et piperazine et leur utilisation pour traiter les infections virales et le cancer
NO20072444L (no) Karbamatforbindelser for anvendelse i behandling av neurodegenerative forstyrrelser
KR20080013933A (ko) 레닌 억제제로서의 치환된 피페리딘
TW200944509A (en) Selective preparation of substituted pyrimidines

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application